EVEON gave a presentation at MedTech Session for Semcion Europa, on October 25, in Grenoble (France).

EVEON announces the release of its new prototype, which reconstitutes lyophilised drugs in just two steps, with no handling or contact with the product.

STMicroelectronics Grenoble and EVEON have signed a partnership agreement aimed at supplying components to be used in new generation medical devices developed by EVEON that will respond to the growing demand for injectable biological treatments.

EVEON gave a presentation at 2016 PDA Europe Advanced Therapy Medicinal Products (ATMPs) Conference, on June 7-8, in Berlin (Germany).

EVEON was presented, in february 2016, with a Pharmapack Europe Award for its device Intuity® Lyo¹ with the special distinction "Convenience and Easy of use".

EVEON gave a presentation at Bioproduction #5 Cell and Gene Therapies B4B connection, in Evry, 3-4 february 2016 

EVEON gave a talk at Medical Device Commercial Leaders Forum, in Brussels, 16-18 February 2016.  

EVEON reaches a major milestone in its development by signing a new industrial partnership agreement in oncology.
The company design an innovative medical device for cancer treatment in the framework of the "CARAT" project which is aimed at developing a French network of excellence in nuclear medicine.

EVEON signed an agreement with the pharmaceutical group Advanced Accelerator Applications for a medical injection device in oncology.
EVEON's objective is to develop and produce an innovative automated injection system for the treatment of solid tumours.

EVEON was awarded, in december 2014, the 1st prize Monday evening in the Inventer Demain (Invent Tomorrow) international competition after winning the vote of an expert jury and the audience.